Academic Journals Database
Disseminating quality controlled scientific knowledge

Another Proliferative Diabetic Retinopathy? A Case Report of Retinal Cavernous Haemangioma Treated with Intravitreal Bevacizumab, Initially Labelled as Persistent Proliferative Diabetic Retinopathy

Author(s): Ahmed Kamal | Ahmad Khalil | Myrto Tsagkataki

Journal: Journal of Biophysical Chemistry
ISSN 2153-036X

Volume: 02;
Issue: 01;
Start page: 5;
Date: 2012;
Original page

Keywords: Retinal Cavernous Haemangioma | Intravitreal Bevacizumab | Persistent Proliferative Diabetic Retinopathy | Vitreous Haemorrhage

We present a case of Retinal Cavernous Haemangioma treated with Intravitreal Bevacizumab, which was initially labelled as persistent proliferative diabetic retinopathy with multiple episodes of vitreous haemorrhage. These lesions can be confused with new retinal vessels in diabetics and if correctly diagnosed unnecessary photocoagulation can be avoided. Our patient received a course of three intravitreal Bevacizumab injections (1.25 mg/0.05 ml) in order to stop the leakage from the retinal cavernous haemangioma lesions and prevent another episode of vitreous haemorrhage. No intraoperative or postoperative complications were seen. Twenty-two months following treatment there was no recurrence of vitreous haemorrhage.
Save time & money - Smart Internet Solutions     

Tango Jona
Tangokurs Rapperswil-Jona